4//SEC Filing
Anand Bhaskar 4
Accession 0001599298-25-000097
CIK 0001599298other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:17 PM ET
Size
8.0 KB
Accession
0001599298-25-000097
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-29+75,000→ 75,000 totalExercise: $17.85Exp: 2035-01-12→ Common Stock (75,000 underlying) - Award
Stock Option (right to buy)
2025-04-29+600,000→ 600,000 totalExercise: $3.85Exp: 2034-04-02→ Common Stock (600,000 underlying)
Footnotes (3)
- [F1]Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on December 31, 2025.
- [F2]Not applicable.
- [F3]Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on January 12, 2026.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:17 PM ET
- Size
- 8.0 KB